"We caught it early." It's the sentence every patient hopes to hear, and the one every breast cancer awareness campaign exists to make possible.
Behind it is a chapter nobody tells. Before anyone says those words, a sample has to be labelled at the right moment, kept in the right conditions and delivered to the lab in time. A slip anywhere along the way and the result a woman is waiting for may be wrong.
October is Breast Cancer Awareness Month, and this is the part of the story diagnostics teams own.
Why Screening Carries So Much Weight
WHO estimates that 2.4 million women were diagnosed with breast cancer in 2024, and 694,000 died. About 80% of breast cancers develop in women with no modifiable risk factor beyond being female and over 40. There's no lifestyle flag to catch, which is why early detection matters so much.
Where the system around diagnosis is strong, it shows: age-standardised breast cancer mortality in high-income countries dropped 40% between the 1980s and 2020, and countries that have succeeded in cutting mortality have managed 2–4% a year.
Why This Is a Diagnostics Story, Not Just an Awareness One
Early detection lives or dies on whether the test result is right the first time. A large share of laboratory errors happen before a sample ever reaches the analyser — mislabelling, poor collection, a broken cold chain, delayed transport. A perfect screening programme still fails a patient if the sample behind her result was compromised before it arrived. Diagnostics teams are not a downstream link in this story; they're the ones holding the early warning steady.
Three Places a Result Can Be Lost
- At collection. Label at the point of collection, not after. Track custody the way you'd track a controlled substance.
- While she waits. A patient waiting on a result she doesn't understand is living the anxiety our patient experience piece described — tell her what to expect and when.
- At capacity. Awareness that sends more women to screening only helps if the lab behind it can absorb the volume without cutting corners.
Try This Week: Trace One Lost Sample
Pick the last sample your lab rejected or delayed. Trace it back, step by step, to the moment it went wrong. One case, followed honestly, often teaches a team more than a dashboard.
Awareness gets a woman to the screening room. The lab decides whether that visit leads anywhere.
Key Takeaways
- 2.4M women diagnosed, 694,000 deaths from breast cancer in 2024 (WHO).
- About 80% of cases occur in women with no modifiable risk factor beyond sex and age — so early detection is the main line of defence.
- Breast cancer mortality in high-income countries fell 40% between the 1980s and 2020 (WHO).
- A reliable result starts at collection: label at the point of collection and track custody.
What's the biggest reason samples get delayed or rejected at your lab? Get in touch, or see our guide to sample collection errors for the full breakdown of where results go wrong before they ever reach the bench.